Novartis NVA237 Phase III data showed rapid, sustained improvement in lung function and symptom relief over one year in COPD patients
17 May 2012 | By Novartis
Results from pivotal Phase III GLOW2 study...
List view / Grid view
News
Teva’s Board of Directors votes to re-elect Dr. Phillip Frost as Chairman of the Board
17 May 2012 | By Teva Pharmaceutical Industries Ltd
“Dr. Phillip Frost has the Board’s full support..."
Amgen’s BiTE® Antibody Blinatumomab achieved high rate of complete response in adult patients with relapsed or refractory acute lymphoblastic leukemia
16 May 2012 | By Amgen
Updated results from a Phase 2 study...
GlaxoSmithKline completes transaction to increase its ownership in Theravance
16 May 2012 | By GlaxoSmithKline
GSK and Theravance, Inc. announced that following approval by Theravance...
Catalent announces winners of Global Academic Competition for Life Science Leaders of Tomorrow
16 May 2012 | By Catalent Pharma Solutions
“This competition allows us to acknowledge some of the world’s best emerging talent..."
Roche will report new data on important progress for people with advanced cancers at ASCO 2012
16 May 2012 | By Roche
Phase III data on Avastin in advanced colorectal and ovarian cancers...
Analysis of rilotumumab data identifies a potential predictive biomarker for patients with gastric or gastroesophageal cancer
16 May 2012 | By Amgen
Exploratory biomarker analysis results...
Avalanche and Lonza announce global manufacturing collaboration for AAV vectors for gene therapy
Avalanche Biotechnologies, Inc., a leader in the area of long-term protein delivery for ocular diseases, and Lonza, a global leader in the field of biologics manufacturing, today announced a manufacturing collaboration focused on process development and scale-up efforts for the manufacturing of adeno-associated viral (AAV) vectors for gene therapy.
ASCO abstracts highlight late-stage Sanofi Oncology pipeline
16 May 2012 | By Sanofi
Progress on Jevtana®, Zaltrap™ and JAK2 inhibitor featured...
Bristol-Myers Squibb Foundation announces $15 million expansion of Together on Diabetes® to China and India
15 May 2012 | By Bristol-Myers Squibb Company
Expansion of Together on Diabetes® initiative to China and India ...
Syrris Asia Heater – flow chemistry 1000x faster
15 May 2012 | By kdm communications limited
Syrris, has developed the fast, flexible and accurate Asia Heater...
Pfizer provides topline results from Phase 3 study of Torisel® as second-line treatment in advanced renal cell carcinoma (RCC)
15 May 2012 | By Pfizer
Pfizer Inc announced that the Phase 3 INTORSECT study...
GlaxoSmithKline to fully acquire Cellzome for £61 million
15 May 2012 | By GlaxoSmithKline
GSK to further expand its platform technology expertise with acquisition of chemical proteomics company...
U.S. FDA approves Bristol-Myers Squibb Devens biologics manufacturing facility
15 May 2012 | By Bristol-Myers Squibb Company
State-of the art Manufacturing Facility Supports Company’s Growing Focus on Biologics...
Abbott’s XIENCE PRIME™ and XIENCE V® Drug Eluting Stents receive indication in Europe
15 May 2012 | By Abbott
New indication supported by data from more than 10,000 patients...
